Abstract:The listing of authors was incorrect in the published version. The correct author names and affiliations appear as above. The authors would like to include the following acknowledgments: We wish to thank Prof. K. Fukunaga (Tohoku University) for generously providing the antibodies (Nitrotyrosine, HtrA2, Fas, Fas ligand and TNFa). We also thank Dr. S. Moriguchi and N. Shioda (Tohoku University) for helpful comments and constructive discussion on the manuscript. Thisworkwas supported in part byNational Natural Science Foundations of China (30672564 to Y. Lou; 30973521 to F. Han), The Science Research Foundation of Chinese Ministry of Health (WKJ2009-2-029 to F. Han), The Key Foundation of Zhejiang Educational Committee (Z200803527 to F. Han) and by the Key Foundation of Modernization of Chinese Traditional Medicine of Zhejiang Province (2006C13075 to Y. Lou). The authors would like to apologize for any inconvenience caused.

Correction: Adema et al. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. Pathogens 2023, 12, 703

Corrigendum for “A Novel Kinase Subverts Aluminium Resistance by Boosting Ornithine Decarboxylase‐dependent Putrescine Biosynthesis”

Publisher Correction: Definitions and guidelines for research on antibiotic persistence

Corrigendum to “the Induction of Reactive Oxygen Species and Loss of Mitochondrial Omi/HtrA2 is Associated with S-nitrosoglutathione-induced Apoptosis in Human Endothelial Cells” [toxicology and Applied Pharmacology 244 (2010) 374–384]

Corrigendum to: Chloro-s-triazenes-toxicokinetic, Toxicodynamic, Human Exposure, and Regulatory Considerations

Author Correction: BHMT Polymorphism and Susceptibility to PTE in Chinese Patients.

Erratum: Synthesis and photodynamic antimicrobial chemotherapy against multi-drug resistant Proteus mirabilis of ornithine-porphyrin conjugates in vitro and in vivo

Correction to "Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance"

Erratum for Estabrook et al., "Epidemiology of Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Study, 2018 to 2019"

Correction: Castelan-Ramírez et al. Schwann Cell Autophagy and Necrosis as Mechanisms of Cell Death by Acanthamoeba. Pathogens 2020, 9, 458

Correction: Furugaito et al. Antimicrobial Susceptibility to 27 Drugs and the Molecular Mechanisms of Macrolide, Tetracycline, and Quinolone Resistance in Gemella sp. Antibiotics 2023, 12, 1538

Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019

Error in Title

Correction: Teng et al. Efficacy Assessment of Phage Therapy in Treating Staphylococcus aureus-Induced Mastitis in Mice. Viruses 2022, 14, 620

Erratum: How to adapt anesthetic human resources to health emergencies such as the COVID-19 outbreak: Replacing a pre-anesthetic consultation with a questionnaire in a university obstetric unit

Corrigendum: Antimicrobial resistance in the COVID-19 landscape: is there an opportunity for anti-infective antibodies and antimicrobial peptides?

Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii

Corrigendum: Development of phage cocktails to treat E. coli catheter-associated urinary tract infection and associated biofilms

Sequential Therapy of Linezolid and Contezolid to Treat Vancomycin-Resistant Enterococcus faecium Pneumonia in a Centenarian Patient: Case Report [Corrigendum]

Erratum: Approaching hemophagocytic lymphohistiocytosis

Erratum: Overview of the RGD-based PET agents use in patients with cardiovascular diseases: A systematic review